ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,780.87
1.64%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Omeros Corporation (OMER) 시세

Omeros Corporation

Omeros Corporation (OMER)

Omer Spa
6.73
0.87
(14.85%)
마감 13 4월 5:00AM
15분 지연
6.73
0.00
(0.00%)
시간외 거래: 6:14AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
6.73
매수가
6.50
매도가
6.77
거래량
826,058
5.802 일간 변동폭 6.77
2.965 52주 범위 13.60
market_cap
390.77M
전일 종가
5.86
개장가
5.87
최근 거래 시간
11
@
6.5067
마지막 거래 시간
재정 규모
US$ 5,216,069
VWAP
6.3144
평균 볼륨(3m)
621,322
발행 주식
58,063,901
배당수익률
-
주가수익률
-3.32
주당순이익(EPS)
-2.03
매출
-
순이익
-117.81M

Omeros Corporation 정보

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injec... Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.omeros.com
본부
Tumwater, Washington, USA
설립됨
-
Omeros Corporation is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker OMER. The last closing price for Omeros was US$5.86. Over the last year, Omeros shares have traded in a share price range of US$ 2.965 to US$ 13.60.

Omeros currently has 58,063,901 shares in issue. The market capitalisation of Omeros is US$340.25 million. Omeros has a price to earnings ratio (PE ratio) of -3.32.

OMER 최신 뉴스

추가 뉴스

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
01 4월 2025
OMER (14.85%)

Form 8-K - Current report
Edgar (US Regulatory)
01 4월 2025
OMER (14.85%)

Form 8-K - Current report
Edgar (US Regulatory)
20 2월 2025
OMER (14.85%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.6-8.185538881317.337.515.63513739626.41622241CS
4-1.29-16.08478802998.029.395.6358702037.58414332CS
12-2.45-26.6884531599.1810.035.6356213228.0924594CS
262.9477.57255936683.7913.63.798477978.5772872CS
523.0482.38482384823.6913.62.9655826937.31534508CS
156117.45200698085.7313.60.927047354.73236942CS
260-6.81-50.295420974913.5425.490.927611628.18168692CS

OMER - Frequently Asked Questions (FAQ)

What is the current Omeros share price?
The current share price of Omeros is US$ 6.73
How many Omeros shares are in issue?
Omeros has 58,063,901 shares in issue
What is the market cap of Omeros?
The market capitalisation of Omeros is USD 340.25M
What is the 1 year trading range for Omeros share price?
Omeros has traded in the range of US$ 2.965 to US$ 13.60 during the past year
What is the PE ratio of Omeros?
The price to earnings ratio of Omeros is -3.32
What is the reporting currency for Omeros?
Omeros reports financial results in USD
What is the latest annual profit for Omeros?
The latest annual profit of Omeros is USD -117.81M
What is the registered address of Omeros?
The registered address for Omeros is 3400 CAPITOL BLVD SE, TUMWATER, WASHINGTON, 98501
What is the Omeros website address?
The website address for Omeros is www.omeros.com
Which industry sector does Omeros operate in?
Omeros operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
85.68M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
29.09M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.75M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
48.09M
MBMasterBeef Group
US$ 3.30
(-90.95%)
2.46M
ATHRAether Holdings Inc
US$ 5.5102
(-87.75%)
581.85k
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.19k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.95M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.09M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.04B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
653.46M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
640.47M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
303.97M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
261.75M

OMER Discussion

게시물 보기
glenn1919 glenn1919 5 월 전
omer................................nice miss.................................
👍️0
TrendTrade2016 TrendTrade2016 5 월 전
OMER MONSTER PLAY OF THE DAY
👍️0
Monksdream Monksdream 1 년 전
OMER new 52=week low
Then bounce
👍️0
shurtha2000 shurtha2000 1 년 전
$341M cash and $12M recievables
👍️0
starkd748 starkd748 2 년 전
Gap filled 6s 7s next top
👍️0
Roadtojourney Roadtojourney 2 년 전
With the type of news this should have been above 5 not sure whats wrong here?
👍️0
starkd748 starkd748 2 년 전
3.20 gap must fill now
👍️0
TheFinalCD TheFinalCD 2 년 전
OMER $200M PAYMENT
👍️0
makinezmoney makinezmoney 2 년 전
$OMER: She back on fire now............ sheeeshhhhhhhhhhhhhh


Go baby goooooooooo.......... $3 breaker upside




GO $OMER
👍️0
starkd748 starkd748 3 년 전
Weeeeeeee
👍️0
starkd748 starkd748 3 년 전
We get some 5s I'm backing up the truck
👍️0
starkd748 starkd748 3 년 전
Was a good trade but it's been done since 7s
👍️0
starkd748 starkd748 3 년 전
Weeeeee
👍️0
starkd748 starkd748 3 년 전
Weeeeeeeeeeeee
👍️0
starkd748 starkd748 3 년 전
Yesss
👍️0
starkd748 starkd748 3 년 전
Looking good
👍️0
starkd748 starkd748 3 년 전
Weeeeee
👍️0
starkd748 starkd748 3 년 전
Yesss
👍️0
starkd748 starkd748 3 년 전
Bounced off the low 3s time to load
👍️0
starkd748 starkd748 3 년 전
Maybe an A B C ... 2.17 might coming
👍️0
starkd748 starkd748 3 년 전
Not ready yet
👍️0
starkd748 starkd748 3 년 전
I like this at a certain fib level hehehe
👍️0
bandit007 bandit007 3 년 전
Great day here! $OMER
👍️0
bandit007 bandit007 3 년 전
Breaking out!
👍️0
bandit007 bandit007 3 년 전
Looking good here. Steady climb
👍️0
bandit007 bandit007 3 년 전
Looking good here. Steady climb
👍️0
Scott 75 Scott 75 3 년 전
Wow! Thanks for sharing. I can't believe with all that going for it and the price is so beaten down.
👍️0
Nefyn Nefyn 3 년 전
So what happens to OMER…a public company with tons of cash and no business operations?
👍️0
JackAskSlap JackAskSlap 3 년 전
Bahhh Bahhh

gonna do this all day long
👍️0
JackAskSlap JackAskSlap 3 년 전
another round for the apes Lets GO !!
👍️0
JackAskSlap JackAskSlap 3 년 전
Glad I'm just a robot no emotions needed
👍️0
JackAskSlap JackAskSlap 3 년 전
Fk with BB My new addiction
👍️0
JackAskSlap JackAskSlap 3 년 전
IN now I'm gonna tick flip this POS to death
👍️0
JackAskSlap JackAskSlap 3 년 전
Trying for the baseline
no holds barred..
👍️0
Jess070283 Jess070283 3 년 전
Load it up!$$$
👍️0
TheGreenReaper TheGreenReaper 3 년 전
OMER$$$$
👍️0
Golden Cross Golden Cross 3 년 전
$14 Targeting
👍️0
crudeoil24 crudeoil24 3 년 전
59M trading float. Huge news out >
👍️0
crudeoil24 crudeoil24 3 년 전
Shorts feeling the heat!!!!! >
👍️0
crudeoil24 crudeoil24 3 년 전
>>>>> GANGBUSTERS <<<<< $$$$$

OMER
👍️0
crudeoil24 crudeoil24 3 년 전
OMER > That is a sweet revenue deal. OMER heading to $20.00+
$125 million upfront payment and $200 million on achievement of commercial milestone
Royalties of 50% on U.S. net sales until the earlier of either January 1, 2025 or payment of the $200-million milestone, after which royalties adjust to 30% of U.S. net sales
Royalties of 15% on ex-U.S. net sales
OMIDRIA to become a premier product in Rayner’s ophthalmology franchise
In addition to acquiring the OMIDRIA commercial organization, including the current OMIDRIA sales force, Rayner plans to further expand its U.S. and ex-U.S. sales forces
👍️0
TheFinalCD TheFinalCD 3 년 전
https://ih.advfn.com/stock-market/NASDAQ/omeros-OMER/stock-news/86711139/omeros-announces-agreement-to-sell-omidria-franch
👍️0
Frankestin Frankestin 3 년 전
Here are the 5!
Very interesting if it goes under!
I would be tempted to open the position now!
👍️0
Frankestin Frankestin 4 년 전
Someone says 5 ... will it get there?
I would like to enter but of course they spend a lot on research and development... and for sell
👍️0
Frankestin Frankestin 4 년 전
ooOOoo
I take a handful these days!
👍️0
Termite7 Termite7 4 년 전
Buying opportunity???
👍️0
frugalNorwegian frugalNorwegian 4 년 전
I created a page on my site talking about OMER. Let me know if I am missing any nuggets. Thanks.

https://frugalnorwegian.com/omer

Summary: This company is a prime candidate for a buyout if FDA approval is given.
👍️0
Dr_Thorfin Dr_Thorfin 4 년 전
If one is worried about fda's delay, Check out @alanrobertross message on StockTwits http://stocktwits.com/alanrobertross/message/333077805
👍️0
umiak umiak 4 년 전
Tute ownership up to 78% been hovering around 50% for years. 20% short
👍️0
umiak umiak 4 년 전
Not new news but I like the smart reporting style:
Omeros's Biologics License Application for Blood Vessel Damage Treatment Candidate Accepted for Priority Review by FDA

1/19/21, 8:06 AM
10:06 AM EST, 01/19/2021 (MT Newswires) -- Omeros (OMER) said Tuesday its biologics license application for narsoplimab, a potential treatment for transplant-associated thrombotic microangiopathy, has been accepted for priority review by the US Food and Drug Administration.

Thrombotic microangiopathy is characterized by a pattern of damage in the small blood vessels.

The FDA has set the Prescription Drug User Fee Act action date on July 17.
👍️0

최근 히스토리

NASDAQ
OMER
Omeros
TSX
PPL.PR.I
Pembina Pipeline
BIBX
BOTBTC
Bodhi [Qtum]
CSE
DDI
Debut Diamonds
TG
BS28
Invesco Markets Ii
COIN
PXPPUSD
PointPay Crypto Banking Token V2
NASDAQ
BSLKW
Bolt Projects
USOTC
WGMCF
Winston Gold (CE)
LSE
V3SS
Vanesgucbed
TSX
VLE
Valeura Energy
LSE
VUAG
Vans&p500
COIN
QRDOUSD
Qredo Token
TG
27G0
Clarity Metals
CRTO
EOSUSD
EOS
BIBX
XNKETH
Ink Protocol
BIBX
TELBTC
Telcoin
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지